Validation of acute myocardial infarction in the food and drug administration's mini-sentinel program

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 1, 2013, Pages 40-54

  Cutrona, Sarah L ^a   Toh, Sengwee ^b   Iyer, Aarthi ^b   Foy, Sarah ^a   Daniel, Gregory W ^e   Nair, Vinit P ^f   Ng, Daniel ^g   Butler, Melissa G ^g   Boudreau, Denise ^h   Forrow, Susan ^b   Goldberg, Robert ^a   Gore, Joel ^c   Mcmanus, David ^c   Racoosin, Judith A ^d   Gurwitz, Jerry H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e BROOKINGS INSTITUTION   (United States)

^f HUMANA INC   (United States)

^g KAISER PERMANENTE   (United States)

^h GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Administrative data; Coronary artery disease; Food and Drug Administration; Mini Sentinel; Myocardial infarction; Pharmacoepidemiology; Validation

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOLOGIST; DISEASE SURVEILLANCE; FEMALE; FOOD AND DRUG ADMINISTRATION; HOSPITAL PATIENT; HUMAN; ICD-9-CM; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SOCIETY; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; DATABASES, FACTUAL; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84872137079     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3310     Document Type: Article

References (37)

1. Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the Sentinel System--a national resource for evidence development. N Engl J Med 2011; 364(6): 498-499.
2. Robb MA, Racoosin JA, Sherman RE, et al. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 9-11.
3. Platt R, Carnahan RM, Brown JS, et al. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 1-8.
4. Goff SL, Feld A, Andrade SE, et al. Administrative data used to identify patients with irritable bowel syndrome. J Clin Epidemiol 2008; 61(6): 617-621.
5. Andrade SE, Gurwitz JH, Chan KA, et al. Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol 2002; 55(3): 310-313.
6. Andrade SE, Graham DJ, Staffa JA, et al. Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol 2005; 58(2): 171-174.
7. Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 23-31.
8. Cutrona SL, Toh S, Iyer A, et al. Design for validation of acute myocardial infarction cases in Mini-Sentinel. Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 274-281.
9. Department of Health and Human Services, Office of the Secretary. Standards for Privacy of Individually Identifiable Health Information; Final Rule. 45 CFR Parts 160 and 164: Federal Register, 2002; 53182-53273.
10. Rosati K, Evans B, McGraw D. HIPAA and Common Rule Compliance in the Mini-Sentinel Pilot. Unpublished White Paper. http://minisentinel.org/work_products/About_Us/HIPAA_and_CommonRuleCompliance_in_the_Mini-SentinelPilot.pdf [8 May 2012].
11. McGraw D, Rosati K, Evans B. A policy framework for public health uses of electronic health data. Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 18-22.
12. Alpert JS, Thygesen K, Jaffe A, White HD. The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart 2008; 94(10): 1335-1341.
13. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50(22): 2173-2195.
14. Tate JR, Bunk DM, Christenson RH, et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010; 42(5):402-408.
15. Fleiss JL, Cohen J, Everitt BS. Large sample standard errors of kappa and weighted kappa. Psychol Bull 1969; 72: 323-327.
16. Kachroo S, Jones N, Reynolds M. Systematic literature review for evaluation of myocardial infarction. Final report prepared for the Foundation for the National Institutes of Health via the Observational Medical Outcomes Partnership (OMOP). United Biosource Corporation: Lexington, MA, 2009.
17. Lux L, Jarrett N, West S. Systematic evaluation of health outcome of interest definitions in observational studies and clinical definitions for the Observational Medical Outcomes Partnership: Myocardial infarction report. Research Triangle Park, NC: RTI International, 2009.
18. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002; 144(2): 290-296.
19. Choma NN, Griffin MR, Huang RL, et al. An algorithm to identify incident myocardial infarction using Medicaid data. Pharmacoepidemiol Drug Saf 2009; 18(11): 1064-1071.
20. Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001; 30(Suppl 1): S30-S34.
21. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004; 148(1): 99-104.
22. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56(2): 124-130.
23. Nguyen-Khoa BA, Goehring EL Jr, Werther W, Gower EW, Do DV, Jones JK. Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 2008; 126(9): 1280-1286.
24. Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005; 12(2): 132-137.
25. Petersen LA, Wright S, Normand SL, Daley J. Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 1999; 14(9): 555-558.
26. Solomon DH, Schneeweiss S, Glynn RJ, et al. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 2004; 109(17): 2068-2073.
27. Varas-Lorenzo C, Castellsague J, Stang MR, Tomas L, Aguado J, Perez-Gutthann S. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf 2008; 17(8): 842-852.
28. Wahl PM, Rodgers K, Schneeweiss S, et al. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf 2010; 19(6): 596-603.
29. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362(23): 2155-2165.
30. Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Gutthann S. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis 2007; 192(2): 376-383.
31. Garcia Rodriguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol 2008; 52(20): 1628-1636.
32. Hammad TA, McAdams MA, Feight A, Iyasu S, Dal Pan GJ. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2008 Dec;17(12):1197-1201.
33. Warner JJ, Weideman RA, Kelly KC, et al. The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor. J Cardiovasc Pharmacol Ther 2008; 13(4): 252-260.
34. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The new Sentinel Network--improving the evidence of medical-product safety. N Engl J Med 2009; 361(7):645-647.
35. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994 Jul;90(1):583-612.
36. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003; 13(9 Suppl): S122-S128.
37. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108(20): 2543-2549.